跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POMBILITI cipaglucosidase alfa 105mg powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
POMBILITI cipaglucosidase alfa 105mg powder for injection vial
Approved
STANDARD
POMBILITI cipaglucosidase alfa 105mg powder for injection vial
Amicus Therapeutics Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
1230deb09803fff1
Company
Amicus Therapeutics Pty Ltd
Type
Standard
Approval Details
Approval Id
1230deb09803fff1
Product Name
POMBILITI cipaglucosidase alfa 105mg powder for injection vial
Artg Id
430450
Artg Name
POMBILITI cipaglucosidase alfa 105mg powder for injection vial
Sponsor
Amicus Therapeutics Pty Ltd
Company Detail Path
/organization/amicus-therapeutics-pty-ltd
Artg Date
2025-02-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5f4384029d61b4328ab711fab08cc56c.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/8d93ada7d3baea76bd3ebcf33c1e75ca.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
1230deb09803fff1
Type
Standard
Back to TGA Approvals